American Journal of Epidemiology Advance Access published online on December 4, 2008
American Journal of Epidemiology, doi:10.1093/aje/kwn338
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contribution |
Leukocyte Telomere Dynamics: Longitudinal Findings Among Young Adults in the Bogalusa Heart Study
Correspondence to Prof. Abraham Aviv, The Center of Human Development and Aging, Room F-464, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103 (e-mail: avivab{at}umdnj.edu).
Received for publication April 30, 2008. Accepted for publication September 22, 2008.
Leukocyte telomere length (LTL) is ostensibly a biomarker of human aging. Cross-sectional analyses have found that LTL is relatively short in a host of aging-related diseases. These studies have also provided indirect estimates of age-dependent LTL shortening. In this paper, the authors report findings of the first comprehensive longitudinal study of 450 whites and 185 African Americans in Louisiana (aged 31.4 and 37.4 years at baseline (1995–1996) and follow-up (2001–2006) examinations, respectively) participating in the Bogalusa Heart Study. Rate of change in LTL was highly variable among individuals, with some displaying a paradoxical gain in LTL during the follow-up period. The most striking observation was that age-dependent LTL shortening was proportional to LTL at baseline examination. At both baseline and follow-up examinations, African Americans had longer LTLs than whites, and smokers had shorter LTLs than nonsmokers. The longer LTL in African Americans than in whites explained in part the faster rate of LTL shortening observed among African Americans. These findings underscore the complexity of leukocyte telomere dynamics in vivo and suggest that determinants in addition to the "end-replication problem" contribute to telomere shortening in vivo.
aging; body mass index; leukocytes; oxidative stress; smoking; telomere
Abbreviations: BMI, body mass index; bp, base pairs; LTL, leukocyte telomere length
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Farzaneh-Far, J. Lin, E. S. Epel, W. S. Harris, E. H. Blackburn, and M. A. Whooley Association of Marine Omega-3 Fatty Acid Levels With Telomeric Aging in Patients With Coronary Heart Disease JAMA, January 20, 2010; 303(3): 250 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ehrlenbach, P. Willeit, S. Kiechl, J. Willeit, M. Reindl, K. Schanda, F. Kronenberg, and A. Brandstatter Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay Int. J. Epidemiol., December 1, 2009; 38(6): 1725 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aviv Commentary: Raising the bar on telomere epidemiology Int. J. Epidemiol., December 1, 2009; 38(6): 1735 - 1736. [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Salomons, G. A. Mulder, L. van de Zande, M. F. Haussmann, M. H. K. Linskens, and S. Verhulst Telomere shortening and survival in free-living corvids Proc R Soc B, September 7, 2009; 276(1670): 3157 - 3165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Re and J. L. Cook Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H893 - H901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aviv Leukocyte Telomere Length, Hypertension, and Atherosclerosis: Are There Potential Mechanistic Explanations? Hypertension, April 1, 2009; 53(4): 590 - 591. [Full Text] [PDF]
|
|